Genetronics , Inc. is a leader in electroporation therapy with over 200 patents issued, allowed, or pending. Genetronics , Inc. utilizes its proprietary electroporation technology for the targeted intracellular delivery of therapeutic materials, concentrating on drugs, vaccines, and gene therapy. In oncology, it has initiated Phase III clinical trials for the treatment of recurrent head & neck cancer. In gene therapy, it has several collaborations with major biotechnology and pharmaceutical companies for the delivery of therapeutic genes or vaccines using electroporation

http://www.genetronics.com/